Click the links below for updates on the latest regulatory initiatives.

 















1/11/2017 - FDA ISSUES FINAL GUIDANCE DOCUMENT ON WARNINGS REGARDING SERIOUS SKIN REACTIONS FOR OTC ACETAMINOPHEN-CONTAINING PRODUCTS